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Abstract.  Treatment of human platelets by EDTA 
(5 mM at 37~  and pH 7.4 for 30 min) induces ultra- 
structural morphological changes of the surface- 
connected canalicular system (SCCS).  The first con- 
sists in dilations of some portions of the channels, 
whereas the second is represented by collapse of parts 
of the canaliculi.  The collapsed elements of the EDTA 
treated SCCS are made up of two parallel limiting 
membranes and a central striated zone.  Some of the 
EDTA treated platelets form microaggregates,  the co- 
hesion of which is apparently due to the appearance of 
pentalaminar  interplatelet structures.  EDTA treatment 
is known to induce an irreversible loss of platelet ag- 
gregability which is due to irreversible dissociation of 
the membrane GPl/b-lIIa complexes. In the present 
study, we looked for involvement of GPIIb-IIIa in the 
formation of these pentalaminar  structures,  and were 
able to demonstrate that the morphological changes 
described are in fact directly dependent on the EDTA 
induced dissociation of GPITo-IIIa  complexes. Indeed, 
we observed that these changes (a) cannot be induced 
in type I Glanzmann's  thrombasthenia,  where GPHb- 
IIIa complexes are absent,  (b) do not appear when hu- 
man platelets are preincubated with monoclonal anti- 
GPIIb-IIIa complex-dependent (CD41a) antibodies, 
which protect the complex from EDTA induced dis- 
sociation,  (c) appear only at alkaline pH and at 37~ 
which corresponds to the range of pH and temperature 
where EDTA can dissociate GPIIb-IIIa complexes, (d) 
are accompanied by the disappearance in fluorescence 
flow cytometry of the heterodimer complex-dependent 
epitopes, when using anti-CD41a antibodies and (e) do 
not appear in rat platelets,  where GPllb-IIIa does not 
dissociate after EDTA treatment.  Furthermore,  using 
gold-labeled mAbs concomitantly with the addition of 
EDTA,  we observed that almost only GPfib was pres- 
ent in the collapsed regions of the canaliculi.  Using 
double labeling Studies  with polyclonal anti-GPllb an- 
tibodies coupled to  10 nm gold particles and poly- 
clonal anti-GPIIIa antibodies coupled to 20 nm gold 
particles,  we observed that while both 10 and 20 nm 
particles were present in the dilated portions of the 
canaliculi almost only the small particles,  coupled to 
the anti-GPIIb antibodies, labeled the collapsed por- 
tions of the SCCS.  On Lowicryl thin sections, poly- 
clonal antibodies against GPIIb labeled the central 
striated zone while both GPIIb and GPIIIa were found 
in the dilated portions of the SCCS.  All these observa- 
tions lead us to suggest that homopolymers of GPIIb 
could be responsible for "zipping" of the SCCS. 
Ir~CE the early observations by Zucker and Borelli (28) 
and by White (25),  it is well known that the divalent 
cation  chelator  EDTA,  which  is  used  as  an  an- 
ticoagulant,  is responsible for changes in platelet  morphol- 
ogy. Indeed, platelets  incubated with EDTA at 37"C, either 
in  plasma  or in physiological  media,  become irregularly 
swollen with multiple pseudopods and loss of granule con- 
tent.  Moreover,  at the ultrastructural  level, White (25) no- 
riced that EDTA induces modificatior, s of the platelet mem- 
brane  surfaces in contact with the  extracellular  medium, 
i.e., both the membranes forming the call wall and those lin- 
ing the surface-connected canalicular  system (SCCS) ~. The 
latter is the site of two types of modification:  the first consists 
in massive dilation of the SCCS channels whereas the second 
is represented by collapse of some portions of the SCCS, 
which become narrow and elongated,  following serpentine 
courses through the cytoplasm. The hypothesis put forward 
by White  (25)  to  explain  the occurrence  of these  SCCS 
modifications  was that dilation of some parts of the channels 
1. Abbreviations used in this paper: CIE, crossed immunoelectrophoresis; 
GP, glycoprotein;  SCCS,  surface-connected canalicular system. 
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pearance. 
On the other hand, when human platelets are incubated for 
30 min at 37"C with 5 mM EDTA and then resuspended in 
a calcium containing  medium, they lose their ability to bind 
fibrinogen and to aggregate in response to ADP stimulation 
(29).  This effect of EDTA is irreversible.  It has been shown 
by crossed immunoelectrophoresis  (CIE) (20), binding  of 
mAb (15) and sucrose density gradient centrifugation  (12), 
that under these conditions,  EDTA dissociates the platelet 
membrane associated specific integrin  a~/53. This integrin, 
also called glycoprotein (GP) llb-lIIa, is a calcium-depen- 
dent glycoprotein heterodimer complex. It is essential  for 
platelet aggregation,  as it serves as an inducible receptor for 
the adhesive proteins fibrinogen, fibronectin, vitronectin and 
von Willebrand  factor upon platelet stimulation  (18). These 
adhesive proteins circulate in plasma and are contained in 
platelet c~ granules.  They all contain RGD (Arg-Gly-Asp) se- 
quences and bind to the activated GPI~-IIIa complex in an 
RGD dependent manner  (10, 18). In patients  with Glanz- 
mann's thrombasthenia,  an inherited autosomal hemorrhagic 
disorder,  the GP IIb-IIIa complex is either absent (type I), 
reduced or abnormal (variants). Their platelets are therefore 
unable to bind fibrinogen when activated by an agonist and 
consequently do not aggregate  (7). 
The purpose of our study was to re-examine the ultrastruc- 
rural  modifications  induced by EDTA in the SCCS and to 
look for possible involvement  of the Olnb/~3 integrin  in the 
genesis of these changes. 
Materials and Methods 
Monoclonal and Polyclonal  Antibodies 
Two different murine mAbs anti-CD41a (24), detecting specifically GPIIb- 
IIla complex-dependent  epitopes,  were  used:  IOP41a (IgG1) from Im- 
munotech  (MarseiUe, France)  and  AP-2  ([gG1) kindly  supplied  by  Dr. 
1". J. Kunicki (The Blood Center of Southeastern Wisconsin,  Milwaukee, 
WI) (19). The following murine mAbs were used to identify the two GPllb- 
Ilia subunits:  D33  (IgG1) kindly  supplied by Dr.  G.  Marguerie  (Centre 
d'Emdes Nucl6aires, INSERM U.217, Grenoble, France) which detect the 
GPfib subunit and IOtRil (IgG1) from Immunotech, which identify the GP- 
HIa subanit.  A polyclonal antiserum anti-GPlIIa  was provided by Dr. B. 
Steiner (Hoffmann-La-Roche and Co., Basel, Switzerland) and a purified 
polyclonai anti-GPIlb antibody was obtained from Dr. J. Sixma (University 
Hospital Utrecht, Department of Haematology, Utrecht, The Netherlands). 
For isotype controls, an irrelevant mouse IgG1 mAb anti-rat kappa chain 
(Immunoteeh) was employed. An F1TC-conjugated goat anti-mouse anti- 
body  (Becton  Dickinson,  Mountain  View, CA)  was  used  for  the  im- 
munofluorescent labeling procedures. 
Gold-labeled antibodies were prepared as already described (8). Briefly, 
gold particles were produced according to the method of Frens (5). The con- 
centration of immunoglobulin necessary to stabilize the colloidal gold parti- 
cles was estimated as previously described by Fanlk and Taylor (4). Accord- 
ing to these results, the mAb IOP41a (anti-GPI/b-IIIa),  D33 (anti-GPIlb) 
and IOP61 (anti-GPIT[a) were adsorbed to 10-nm gold particles,  whereas 
the polyclonal anti-GPHb and anti-GPIIla antisera were conjugated to 10 
and 20 ran gold particles, respectively. Tween 20 was added as stabilizer. 
Gold-labeled (10 run) secondary antibodies (BioCeU Research Laboratories, 
Cardiff, UK) used for immunocytochemical procedures are listed in Table I. 
The specificity  and  origin  of the polyclonal  antibodies  employed in 
immunocytochemical  procedures  on Lowicryl  sections are described  in 
Table I. 
Preparation of Washed Human Platelets 
Blood was obtained from healthy human donors and from a patient with 
type I Glanzmann's thrombasthenia,  who denied taking any drugs for at 
least 8 d before blood collection. Platelets were isolated from acid-citrate- 
dextrose  anticoagulated  blood by differential centrifugation  and  washed 
twice at 370C according to a modification (3) of  the method of Mustard (16). 
Unless otherwise stated, platelets were washed in Tyrode's buffer, pH 7.3, 
295 mOsmol,  containing  5 mM Hepes (Sigma Chemical  Co, St. Louis, 
MO)  (~rode's-Hepes  buffer),  0.35%  purified  human  serum  albumin 
(CRTS, Strasbolh-'g, France)  and  1 ~  prostaglandin  I2 (PGI2) (Sigma 
Chemical Co.).  Platelets were finally suspended in "Pyrode's-Hepes  buffer 
containing 0.35% human serum albumin and 2/~g/ml apyrase and adjusted 
to ,,,500,000 platelets/mm 3. 
EDTA Treatment of  Human Platelets 
For EDTA trea~nent a solution of 0.1 M EDTA (Sigma Chemical Co.), pre- 
viously warmed to 37"C, was added to the washed human platelets in the 
second washing fluid, the final concentration of EDTA being 5 raM. Care 
was taken to maintain pH 7.3 and temperature  370C when not otherwise 
stated. Control platelets were similarly incubated with the same volume of 
Tyrode's buffer containing neither Ca  2+ nor Mg  2+. After 30 rain, control 
and EDTA treated platelets were fixed for EM studies. 
Preparation and EDTA Treatment of Washed 
Rat Platelets 
Wistar rat blood (5 vol) was collected from the aorta under ether anesthesia 
and anticengulated with acid-citrate-dextrose (1 vol), Platelets were isolated 
by differential centrifugation  and washed twice as already described  (6). 
Table L List of  the Antibodies Used  for Immunocytochemical Procedures 
Primary polyclonal antibodies 
Antibody to 
human  Host animal  Dilution  Origia  Gold-labeled secondary antibodies 
GP I1b  Rabbit  1:250 
GP Ilia  Rabbit  1:250 
Fibrinogen  Rabbit  1:2,500 
yon Willebrand  Rabbit  1:1,000 
factor 
Vitronectin  Rabbit  1:500 
Thrombospondin  Rabbit  1:500 
Fibronectin  Sheep  1:1,000 
DR Phillips, 
San Francisco, CA 
Cor Therapeutics, 
San Francisco, CA 
CRTS, Strasbourg, 
France 
CRTS, Strasbourg, 
France 
Calbiochem, Corp., 
La Jolla, CA 
Diagnostica Stago, 
Asni~res, France 
The Binding Site, 
Birmingham, UK 
Goat anf-rabbit IgG 
Donkey anti-sheep  IgG 
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some experiments, EITrA was added to the second washing fluid (final con- 
centration of EIYI'A 5 raM) for 30 rain, the platelets then being fixed for 
EM studies.  Particular care was taken to maintain the pH constant at Z4 
or 8.5. Controls were performed by adding only Tyrode's-Hepes  buffer to 
the platelets  in suspension, pH again being maintained at 7.4 or 8.5. 
Incubation with Antibodies 
Washed human platelet suspensions were incubated with the mouse mAb 
lOP41a or AP-2, detecting specifically  GPIlb-HIa complex-dependent epi- 
topes, or with the irrelevant mouse mAb anti-rat kappa chain before (first 
wash) and during (second wash) EDTA treatment (0.1 mg/rnl final concen- 
tration of antibody). After 30 rain incubation in the presence of EDTA, 
platelet suspensions were processed for EM or for CIE. In the same way, 
untreated platelets were processed for EM or CIE. In another set of experi- 
ments,  gold  labeled  antibodies  against the  GPllb-Illa complex  or  its 
subunits GPIFo and GPI~, were added to the platelet suspensions at the 
time of ED'I'A treatment. After 30 rain incubation at 370C platelets were 
fixed for EM. 
Crossed lmmunoelectrophoresis 
Untreated and EDTA treated platelets (preincubated or not with a mAb anti- 
GPlrv-IIIa or an irrelevant mAb) were sedimented and washed in Tyrode's- 
Hepes buffer containing no albumin, to remove excess albumin. After cen- 
trifugation, the pellet was resuspended in 0.t M glyeine,  38 m/vl Tris, pH 
8.7 (Tris-glycine),  prechilled to 4"C. Platelet solubilization  was performed 
by incubating the platelets for 30 rain at 4"C with 1% (vol/vol) Triton X-100 
in Tris-glyr  Triton insoluble material was removed by ultracentrifuga- 
tion at 100,000 g for 10 rain and the supernatant stored at -80"C until use. 
CIE was carried out on platelet extracts as previously described (6). Briefly, 
70/~g of solubilized platelets  was first electrophoresed at 10 V/cm for 1 h 
into 1% (wt/vol) agarose containing 0.5% (vol/vol) Triton X-100 in Tris- 
glyeine.  Second dimension electrophoresis was performed at 2 V/cm for 
18 h into a biphasie gel system. An intermediate I% agarose, 0.5% Triton 
X-100 gel was present between the first dimension and the upper gel con- 
taining precipitating concentrations of polyspecific rabbit antiplatelet anti- 
bodies. Immunoprecipitates were located by Coomassie blue staining (CB- 
R-250, Bio-Rad  Labs, Richmond, CA). 
Flow Cytometry 
Control and EDTA treated platelets,  washed once in Tyrode's-Hepes  buffer, 
wore fixed with 2 % paraformaldehyde  in Tyrode's-Hepes  buffer for 30 rain 
at 37"C and washed again in ~yrode's-Hepes  buffer. 2/~g of the primary 
mAb anti-GPnb-IHa or the irrelevant mAb anti-rat kappa chain was then 
added to 5-/zl aliquots (5  ￿  105 plateletsf/~l) diluted in 50 t~l Tyrode's- 
Hepes buffer, for 30 rain at room temperature. After washing the platelets 
with Tyrode's-Hepes  buffer, 10/tg of FITC-labeled goat anti-mouse IgG was 
added, for 30 rain in the dark at room temperature, to 50-td aiiquots of the 
platelet suspensions.  Samples  were  again washed with Tyrode's-Hepes 
buffer and then diluted in 1 ml Isoton HI (Coultertronics,  Paris,  France). 
5,000 platelets were analyzed for each sample using a Facscan flow cytome- 
ter (Becton-Dickinson) gated to exclude  nucleated cells. 
Preparation of  Platelets for Transmission 
Electron Microscopy 
Washed platelets (control and EDTA treated) were processed either for 
Epon or for Lowieryl  embedding.  For Epen embedding, washed platelets 
(1 rnl) maintained at 37"C were fixed by adding an equal volume of fixative 
solution, previously warmed to 37"C, composed of 1.5% glutaraldehyde  in 
0.1 M Na cacodylate buffer containing 1% sucrose, pH 7.3. After 5 rain the 
mixture was centrifuged, the supernatant discarded and the platelet pellet 
resuspended and further fixed for 1 h at 37*C in the same fixative solution. 
Following an additional centrifugation, the samples were incubated for 1 h 
at room temperature with 1% tannic acid in 0.05 M Na eacodylate buffer, 
pH 7.0. They were then posttixed for 1 h at 4~  with 1% osmium tetroxide 
in 0.1 M  cacodylate buffer, pH 7.3. Platelets  were washed once more in 
0.1 M Na eacodylate buffer, pH 7.3, for 10 rain at room temperature before 
being stained for 1 h at 4"C with a 1% aqueous solution of uranyl acetate 
and dehydrated in successively  increasing (50, 70, 80, 95, and 100%)etha- 
nol concentrations. Finally, the samples were incubated overnight in Epon- 
absolute alcohol (1:1, vol/vol) and embedded in Epon. Ultrathin sections, 
stained with lead citrate, were examined under a Siemens  Elmiscope 102 
electron microscope (60kV). For l.x~icryl embedding,  samples of washed 
platelets (1 ml) were fixed in two different ways. Firstly, they were incubated 
at 37~  for 10 rain with an equal volume of 1.5% glutaraldehyde  in 0.I M 
Na cacodylate buffer, pH 7.3. This mixture was then replaced by the same 
fixative and the platelets further fixed for 1 h at 20~  Secondly,  1 ml of 
5 % parafDrmaldehyde, 0.2 % glutaraldehyde  in 0.2 M Na cacodylate buffer 
(pH 7.3) was added to the platelet samples  maintained at 37"C.  After 10 
rain incubation, the mixture was replaced by 2.5 % paraformaidehyde,  0.1% 
glutaraldehyde  in 0.1 M Na eacodylate buffer (pH 7.3) and the samples fur- 
ther fixed for 1 h at 20"C. Thereafter, the platelets fixed in either of the two 
ways were washed once in 0.1 M Na cacodylate buffer, concentrated in agar 
(27) and further washed overnight at 4~  in 0.1 M Na eacodylate buffer. 
After 30 min staining at 4"C with 2% uranyl acetate diluted in Michaelis 
buffer, dehydration and Lowicryl K4M embedding procedures were carried 
out as previously described by Whitehouse et ai. (26). 
Immunocytochemical Procedures 
Thin sections of Lowicryl embedded samples were collected on 200 mesh 
Formvar-earbon coated nickel grids (Agar, Stansted, UK). These sections 
were pretreated for 1 h at room temperature with PBS (pH 7.2) containing 
1% serum of the same origin as the second antibody.  They ware then in- 
cubated for 16 h at room temperature with the primary antibody (dilutions 
of the various primary antibodies are given in Table I). Thereafter,  the sec- 
tions were washed three times in PBS/I% serum and further incubated for 
1.5 h at room temperature with the gold labeled secondary antibody used 
at 1:20 dilution in PBS/I% serum (the nature of the secondary antibody 
varies according to the primary antibody as detailed in Table I). After twv 
washes in PBSI0.5 % serum and two washes with PBS, the sections were 
postfixed for 30 rain at room temperature with 2.5 % glutaraldehyde  in PBS. 
Finally, the sections were washed with distilled water and coated with 1.8% 
uranyl acetate/0.2 % methylcellulose  (22). They were examined under a Sie- 
mens Elmiscope  102 electron microscope (80 IN).  Controls were per- 
formed by substituting non immune rabbit or sheep IgG for the primary an- 
tibody. 
Results 
Ultrastructural Effects of  EDTA on Normal 
Human Platelets 
Treatment of normal human platelets by EDTA induced the 
previously described morphological changes, i.e.,  increase 
in platelet volume, shape change from disc to sphere and de- 
granulation.  At the ultrastructural  level the  SCCS,  which 
normally appears as a mass of unconnected short tubules and 
small vacuoles (Fig. 1 a), presented the dilated and collapsed 
portions already mentioned (Fig.  1 b) (25). The SCCS re- 
mained in continuity with the cell surface (Fig.  1 c) and ex- 
tended  through  the  cytoplasm,  describing  over  variable 
lengths  straight or more or less winding  trajectories.  The 
collapsed elements of the EDTA treated SCCS were made up 
of two parallel limiting membranes and a central irregular 
striated zone ffig. 1 d), formed by the juxtaposition of small 
lumps with rounded or angular contours (Fig.  1 e). Some of 
the EDTA-treated platelets formed microaggregates  (Fig.  1 
f).  The cohesion of the platelets in these microaggregates 
seemed to be due to the appearance of pentalaminar  inter- 
platelet structures. 
Ultrastructural Effect of  El~A on Platelets  from a 
l~pe I Glanzmann's Thrombasthenia Patient 
Washed platelets from a type I Glanzmann's thrombasthenia 
patient, i.e., platelets lacking the GPIIb-lIIa complex, were 
incubated with EDTA 5  mM for 30 rain at 37~  and then 
fixed for EM. Fig. 2 shows that these platelets did not display 
the typical features observed after EDTA treatment of nor- 
mal platelets. Indeed, despite dilation of some portions of the 
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fects of EITI'A  on the SCCS of 
normal human platelets. Tan- 
nic acid enhances the contrast 
of the channels of the SCCS 
which appear, on thin sections, 
in  untreated  human  blood 
platelets  (a)  as unconnected, 
more or less dilated vacuoles 
or canaliculi and after EDTA 
treatment  (b-e) as composed 
of dilated zones and zones of 
collapse.  The  EDTA treated 
SCCS  remained  in  continu- 
ity  (c)  with  the  cell  surface 
(arrows). Continuity  is  also 
clearly visible between the di- 
lated  and collapsed  portions 
of the EI)TA treated SCCS (c, 
d), which can take a "piles of 
plates"  arrangement  (d).  A 
higher magnification of these 
elements of the SCCS shows 
(d, inset) that they are made 
up  of  two  parallel  limiting 
membranes  and  a central  ir- 
regular  striated  zone.  On  a 
section parallel to the plane of 
an element of the SCCS (e), 
this  striation  appears  to  be 
formed by the juxtaposition of 
small lumps with rounded or 
angular contours. Similar stri- 
ation is also visible at a zone 
of contact  between  two  ad- 
jacent platelets (arrows), in an 
EDTA treated human platelet 
microaggregate (f). 
SCCS, no collapsed regions were detected, suggesting that 
the  GPIlb-IIIa complex is  essential  in  the genesis  of this 
phenomenon.  Likewise,  no platelet microaggregates were 
observed when type I Glanzmann's thrombasthenia platelets 
were subjected to EDTA treatment. 
The Pentalaminar Structures Induced 
by EDTA Appear Only when the GP lib-Ilia Complex 
is Dissociated 
When human platelets were incubated with EDTA 5 mM, ei- 
ther at pH 7.3 and room temperature or at 37~  and pH <  7, 
the typical pentalaminar structures  induced by incubating 
platelets with EDTA at 37~  and pH 7.3 did not appear. Flow 
cytometry  performed  using  the  mAb  IOP41a,  detecting 
specifically  GPIIb-IIIa complex-dependent  epitopes,  re- 
vealed that  at  room temperature  (pH  Z3)  the  GPIFo-IIIa 
complex did  not dissociate.  Similarly,  at pH <  7  (37~ 
platelets were still labeled with the complex specific anti- 
body (Fig. 3). These results are closely related to the obser- 
vations of Zucker and Grant (29) and of Pidard et al. (20), 
who noted the temperature and pH dependence of EDnA in- 
duced loss of aggregability due to GPHb-HIa dissociation 
(20). Thus, dissociation of the GPIIb-IIIa  complex seems to 
be necessary for induction of pentalaminar structures in the 
SCCS.  This conclusion was confirmed by further experi- 
ments where washed human platelets were incubated with 
anti-GPlIb-BIa complex-dependent  mAb  (AP-2,  IOP41a) 
before and during EDTA treatment (5 mM, 37~  pH Z3). 
Under these conditions, despite dilation of some regions of 
The Journal of Cell Biology, Volume 120, 1993  1024 Figure 2. Ultrastructural  effects of EDTA on the platelet SCCS of 
a type I Glanzmann's thrombasthenia patient.  Despite dilation of 
some portions of the SCCS, no collapsed regions are visible. 
the SCCS, no pentalaminar structure formation could be ob- 
served in the EDTA treated platelets, whereas addition of an 
irrelevant mAb did not prevent the appearance of SCCS pen- 
talaminar structures.  CIE (Fig. 4) revealed that preincubat- 
ing  the  platelets  with  anti-GPIlb-IIIa complex-dependent 
mAb protected the complex from EDTA induced dissocia- 
tion (Fig. 4 D), while addition of an irrelevant mAb did not 
prevent this dissociation (Fig. 4 C). Thus, we deduced once 
again that by preventing GPHb-l]Ia dissociation, one could 
preclude the formation of the SCCS pentalaminar structures. 
Our conclusion was reinforced by additional data. We have 
previously shown (6) that rat platelets are less sensitive to 
the effects of EDTA than human platelets and that the GPIIb- 
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Figure 3. Temperature and pH dependence of EDTA induced dis- 
sociation of  the GPUb-IIIa  complex. Flow cytometric profiles using 
the  mAb IOP41a, detecting  GPllb-IIIa complex-dependent  epi- 
topes, are displayed in the right column, whereas profiles obtained 
with  an irrelevant  mAb are indicated  on the  left.  The complex 
specific epitopes did not disappear when platelets were incubated 
with EDTA at 37~  and pH < 7 or at pH Z3 and at room tempera- 
ture. Loss of the epitopes visualized by a decrease in fluorescence 
intensity, occurred at 37~  and pH 7.3, the well known conditions 
in which GPIIb-IIIa  dissociates under  EDTA treatment. 
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GPlIb-IIIa  complex  from EDTA induced  dissociation.  Human 
platelets, treated or not with 5 mM EDTA at 37~  and pH 7.4, in 
the presence or not of mAb AP2 or an irrelevant mAb, as described 
in the Methods section, were solubilized in Triton X-100 and sub- 
mitted to crossed immunoelectrophoresis. The gels were stained 
with Coomassie blue. (A) control platelets, (B) EDTA  treated plate- 
lets, (6")  EDTA treated platelets incubated with an irrelevant mAb, 
(D) EDTA treated platelets incubated with AP2. Under conditions 
(A) and (D), the GPIIb-IIIa complex did not dissociate. 
IIIa complex of rat platelets does not dissociate under condi- 
tions (37~  pH 7.4, 30 min) where the human complex is 
almost  completely  dissociated.  When  EDTA  treated  rat 
platelets (37~  pH 7.4, 30 min) were examined by EM, we 
did not observe pentalaminar structures (Fig. 5 a) along the 
SCCS.  However, when  rat platelets  were  incubated  with 
EDTA 5 mM at 37"C and pH 8.5,  few but typical pentala- 
minar structures appeared (Fig. 5, b and c). Under these con- 
ditions,  20%  of the rat GPllb-IIIa complexes are dissoci- 
ated (6). 
Nature of the Glycoproteins Involved in the 
Pentalaminar Structures 
As  dissociation of the ot~fl3 integrin leads to the appear- 
ance of monomeric subunits, i.e., free GPIlb and GPIIIa, as 
well as  homo and/or heteroglycoprotein polymers (2,  17, 
21), we attempted to identify the glycoprotein(s) involved in 
the EDTA induced "zipping" of the SCCS. In a first set ofex- 
periments (Fig.  6  A),  we incubated control platelets with 
gold-labeled antibodies against free GPHb (the polyclonal 
antiserum coupled to 10 nm gold particles) and free GPIIIa 
(the polyclonal antiserum coupled to 20 nm gold particles) 
at 37~  pH 7.4 and for 30 rain. Under the EM gold particles 
of both sizes were observed within the short tubules  and 
small vacuoles of the SCCS,  while there was only sparse 
labeling of the plasma membrane. These results are closely 
related to the observations of Isenberg et al. (11), who noted 
that incubation of platelets at 37~  in the presence of gold- 
labeled anti-GPIIb and anti-GPlIIa mAb induces internaliza- 
tion and a surface membrane clearing of  GPIlb-IHa. In a sec- 
ond set of experiments, these two types of antibodies were 
added to the platelet suspensions concomitantly with the ad- 
dition of EDTA. We then observed that while anti-GPIIIa 
and anti-GPIIb antibodies were both present in the dilated 
portions of the SCCS, almost only the anti-GPllb antibody 
was present in the collapsed portions of the canaliculi (Fig. 
6, B  and  C).  These results reproduced those we obtained 
using either gold labeled mAb anti-GPHb-IIIa or anti-GPIlb 
or anti-GPllIa concomitantly with the addition of EDTA: 
while all the gold labeled mAb were present in the dilated 
portions of the SCCS, almost only the mAb anti-GPHb was 
present in the collapsed portions of the canaliculi. 
To identify a possible ligand, which could be located in the 
striated zone and participate through "ligand-receptor" inter- 
actions in collapse of the SCCS, we incubated I.x~icryl thin 
sections successively with (a) polyclonal antibodies against 
the major platelet adhesion molecules (fibrinogen, fibronec- 
tin, vitronectin, von Willebrand factor and thrombospondin) 
and (b) a gold-labeled secondary reagent. In control plate- 
lets, all these antibodies stained the a  granules, where these 
adhesion  molecules  are  normally  located.  When  EDTA 
treated platelets were examined, c~ granule staining was less 
pronounced, as could be expected by taking into account a 
certain degree of EDTA induced granule secretion.  How- 
ever, no staining of the pentalaminar structures could be de- 
tected (not shown). It was essentially with the polyclonal an- 
tibody to  GPI/b  that  we  observed (Fig.  7,  a  and  b),  on 
paraformaldehyde/glutaraldehyde fixed platelets (23), label- 
ing of the limiting membranes and also of the striated zone 
of the collapsed regions of the SCCS.  Less often, we ob- 
served labeling with the polyclonal anti-GPllla antibody and 
rarely  with  the  anti-GPl/b-IIIa  complex-dependent mAb, 
IOP41a. 
Discussion 
In this study, we show that the previously described EDTA 
induced morphological modifications of the platelet SCCS 
are directly dependent on the presence and dissociation of 
the platelet specific Ottr,  B3 integrin.  The prominent feature 
we have observed was the appearance (Fig. 1) of pentalami- 
nar structures made up of two parallel limiting membranes 
with a central striated zone. Although mainly located in the 
SCCS, pentalaminar structures were also found between the 
EDTA treated platelets, where they seemed to be responsible 
for the cohesion of small platelet aggregates. This is in agree- 
ment with the findings of White (25) who pointed out that 
the effect of EDTA was "limited to membranes exposed to 
plasma since previous work has shown that EDTA does not 
enter the  living cells:  The necessity  for the  presence of 
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EDTA induced collapse of rat 
platelet  SCCS.  Incubation of 
rat platelets with 5 mM EDTA 
at 37~  and pH 7.4 (a) did not 
induce the appearance of col- 
lapsed  regions  along  the 
SCCS. Under the same condi- 
tions but at pH 8.5 (b, c), typi- 
cal  pentalaminar  structures 
appeared  (arrows)  in  some 
parts of the SCCS. 
Gachet et  al. Morphological Consequences of  c~#~  ~s Dissociation  1027 GPIIb-IIIa was deduced from the observation that in type I 
Glanzmann's thrombasthenia platelets, i.e., platelets lacking 
almost completely the GPIIb-l/Ia complex, these pentalami- 
nar elements did not appear after EDTA treatment (Fig. 2). 
The necessity for GPIIb-llIa to dissociate was supported by 
a series of arguments. First, by the observation that these ele- 
ments appear only under conditions where the GPllb-ma 
complex can be dissociated by EDTA, namely, when incuba- 
tion is performed for 30 min at 37~  and pH 7.4. It is well 
known that at acidic pH (< 7) and/or at temperatures below 
37~  the GPIlb-RIa complex is  not dissociated in intact 
platelets exposed to 5 mM EDTA (2, 20). We showed that 
under these conditions (pH <  7, T ~ <  37~  the pentalami- 
nar structures did not appear and that simultaneously the 
complex-dependent epitopes of GPIIb-ma remained pres- 
ent, as visualized by flow cytometry (Fig. 3). A second argu- 
ment is  represented by our observation that when human 
platelets were incubated before and during EDTA treatment 
(5 mM, 30 min, 37~  with anti-GPllb-IIIa complex-depen- 
dent mAb (AP-2, IOP41a), no pentalaminar structures ap- 
peared in the EDTA treated platelets. As we could demon- 
strate  using  CIE  (Fig.  4),  this  was  not the  result of the 
antibodies  impairing  the  formation  of  the  pentalaminar 
structures after dissociation of the GPllb-IIIa complex, but 
the result of the prevention by these antibodies of the EDTA- 
induced dissociation of the complex.  The mechanism by 
which these mAb prevent dissociation of  the GPllb-IIIa com- 
plex is unclear. They could interact with epitopes close to 
the  Ca  :§  binding  domains  of the  glycoproteins and  thus, 
prevent Ca  2§ chelation, or they might induce a  locking of 
the heterodimer which renders it resistant to dissociation af- 
ter  Ca  2+  chelation.  This  effect of the  complex-dependent 
mAb was specific. Indeed, as CIE studies revealed (Fig. 4 
C), incubation with irrelevant antibodies did not prevent dis- 
sociation of the GPIIb-IIIa complex and, consequently, incu- 
bation of platelets in the presence of irrelevant mAb did not 
prevent appearance of SCCS pentalaminar structures after 
appropriate  EDTA treatment.  A  final  argument  is  drawn 
from  observations  on  rat  platelets.  We  have  previously 
shown (6) that rat platelets are much less sensitive to EDTA 
treatment than human platelets and in particular that the rat 
GPIIb-IIIa complex is not dissociated after long exposure to 
5 mM EDTA at 37~  and pH 7.4. Under these conditions, 
we found that EDTA treated rat platelets did not contain the 
typical structures described in human platelets and that they 
did not form aggregates (Fig. 5 a). However, under drastic 
conditions,  i.e.,  5  mM  EDTA,  37~  and  pH  8.5,  where 
•20%  of the rat GPIIb-llla complexes are dissociated (6), 
we observed that some portions of the rat platelet SCCS dis- 
played the characteristic pentalaminar features (Fig. 5, b and 
c).  Thus,  it was  demonstrated that the occurrence of the 
Figure 6. Colocalization of  gold labeled anti-free GPIIb (10 nm) and 
anti-free GPIIIa (20 nm) polyclonal antibodies in the SCCS. In con- 
trol untreated platelets (,4) gold particles of both sizes are visible 
in the short tubules and the small vacuoles of the SCCS. When the 
two types of antibodies were added concomitantly with EDTA (B), 
both anti-free GPIIb and anti-free GPIIIa were located in the dilated 
portions of  the SCCS, while only anti-free GPIIb localized (arrows) 
in the collapsed regions of the SCCS. C is a higher magnification 
of B. 
The Journal of Cell Biology,  Volume 120, 1993  1028 Figure  7. (a and b) GPlIb localizes in the collapsed regions of the 
SCCS. EDTA treated platelets embedded in Lowicryl K4M were 
incubated successively  with (/) a rabbit polyclonal anti-GPllb anti- 
body and (it) gold-labeled  goat anti-rabbit IgG. Gold particles label 
both the limiting membranes and the central striated zone of the 
collapsed SCCS. 
SCCS pentalaminar structures is directly dependent on dis- 
sociation of the o~ibB3 integrin. 
Because GPIIb-IIIa is the receptor for fibrinogen and other 
platelet adhesion molecules such as fibronectin, vitronectin 
and von Willebrand factor, we looked for the presence of one 
or more of these ligands in the SCCS pentalaminar struc- 
tures. Our hypothesis was that some of these adhesion mole- 
cules could participate, via receptor-ligand interactions, in 
the membrane bonding of the SCCS. We therefore incubated 
Lowicryl thin sections successively with polyclonal antibod- 
ies raised against the major platelet adhesion molecules and 
with the appropriate gold-labeled secondary antibodies. As 
expected, we were able to label the c~ granules of control 
platelets, where these adhesion molecules are normally lo- 
cated. The oe granules of EDTA-treated  platelets were also 
labeled, although this labeling was less pronounced when 
compared to untreated platelets, indicating that a  granule 
secretion occurred under EDTA treatment. However, we did 
not find any staining of the pentalaminar structures of EDTA 
treated platelets with any of the antiadhesion molecule anti- 
bodies tested. These results were in fact not surprising, as 
we have observed (data not shown) that incubation of human 
platelets before and during EDTA treatment with the RGDS 
peptide,  which  is  known  to  interfere  competitively with 
binding  of  RGD  containing  adhesion  molecules  to  the 
GPIIb-IIIa complex, did not prevent the appearance of pen- 
talaminar structures. Likewise, we observed the formation 
of typical pentalaminar structures in platelets from the re- 
cently  described  variant  of Glanzmann's  thrombasthenia 
(14), the GPIIb-IIIa of which is not able to support fibrino- 
gen binding (data not shown).  Although this does not ex- 
clude definitively the possibility that an adhesive protein is 
involved in the bonding of  the pentalaminar structures, it was 
essentially with a polyclonal antibody to free GPIIb subunit 
that we observed a labeling of both the limiting membranes 
and the striated zone of the SCCS collapsed regions (Fig. 7). 
Altogether these  data  suggest that the mechanism which 
leads to zipping of the SCCS does not result from receptor- 
ligand  interactions,  but  rather  from  the  appearance  of 
homopolymers of free GPIIb, "bridging" the limiting mem- 
branes of the channels. Homopolymers of free glycoprotein 
subunits  have  been  described,  after  dissociation  of  the 
GPIIb-IIIa complex, in purified systems (2,  17). Moreover, 
it has been reported that GPIIb could form covalently linked 
homopolymers (disulphide bonded) after 10 min exposure to 
EDTA at 37~  (21). Strikingly, our observations are that the 
kinetics of appearance of the collapsed portions of the SCCS 
correlates well with this report, because it is only after 10 
min incubation with EDTA that the first pentalaminar struc- 
tures do appear in several platelets.  It has been reported very 
recently that activated platelets release a protein disulfide 
isomerase activity (13). Because EDTA induces the release 
of the platelet granule content, it is possible that such an en- 
zyme may participate in the formation of homopolymers of 
GPIIb. A low level of labeling was also found on Lowicryl 
thin sections using polyclonal anti-GPIIla and monoclonal 
anti-GPIIb-IIIa complex-dependent antibodies. Whether this 
labeling resulted only from the presence of remaining non 
dissociated GPIIb-IIIa complexes or also from retention of 
free dissociated GPIIIa in the SCCS is not clear. Neverthe- 
less,  when gold-labeled polyclonal antibodies against free 
GPIIb  and  free  GPIIIa  were  added  simultaneously with 
EDTA,  almost only the anti-GPHb antibodies were present 
in the collapsed portions of the SCCS (Fig.  6, B and C), 
clearly indicating a differential location of the two separate 
subunits along the SCCS after EDTA induced dissociation of 
the GPIIb-IIIa heterodimer complex. These results suggest 
that GPIIb subunits assemble to "bridge" the canaliculi, leav- 
ing most of the free GPIIIa outside the bridge, essentially in 
the dilated portions of the SCCS. The mechanism by which 
dilation of the  EDTA  treated  SCCS  occurs  remains  un- 
known, but seems not to be related to the presence of the 
GPIIb-IIIa complex since in each case studied dilation oc- 
curred even when collapse did not. 
Striking similarities have been reported between the plate- 
let pentalaminar structures induced by EDTA and the typical 
pentalaminar cytoplasmic organelle of epidermal Langer- 
hans cells, the so-called "Birbeck granule" (1, 9). The mech- 
anisms leading to the appearance of Birbeck granules in 
Langerhans cells  remain unknown.  However,  recent data 
have shown that exposure of Langerhans cells to 25  mM 
EDTA  induces  unzipping  of the  Birbeck  granules,  i.e., 
gradual transformation of the rodlike Birbeck granules to 
blown-up vesicles  (1). This  suggests  that divalent cations 
might be important for the interlinking of the Birbeck gran- 
ule's membranes. Thus, EDTA appears to have an opposite 
effect,  according  to  whether  it  is  incubated with human 
platelets ("zipping" of the SCCS) or with human Langerhans 
cells ("unzipping" of the Birbeck granules), 
In conclusion, we have demonstrated that (a)  the ultra- 
structural changes induced by EDTA in the human platelet 
plasma membrane and SCCS, i.e., the appearance of pen- 
talaminar structures, are directly dependent on dissociation 
of the utrd3~ integrin and (b) at least GPIIb participates in 
bonding of the limiting membranes. Because we found no 
platelet adhesion molecule in these structures so far, we sug- 
gest that homopolymers of GPIIb may at least participate in 
the bridging of adjacent SCCS membranes and induce their 
collapse. 
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